Cargando…
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema
Background: Currently, the gold standard of diabetic macular edema (DME) treatment is anti-vascular endothelial growth factor (VEGF) injections, although a percentage of patients do not respond optimally. Vitrectomy with or without internal limiting membrane (ILM) peeling is a well-established treat...
Autores principales: | Ranno, Stefano, Vujosevic, Stela, Mambretti, Manuela, Metrangolo, Cristian, Alkabes, Micol, Rabbiolo, Giovanni, Govetto, Andrea, Carini, Elisa, Nucci, Paolo, Radice, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056256/ https://www.ncbi.nlm.nih.gov/pubmed/36983298 http://dx.doi.org/10.3390/jcm12062297 |
Ejemplares similares
-
Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016) -
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema
por: Ulrich, Jan Niklas
Publicado: (2017) -
Vitrectomy Combined with Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Nontractional Diabetic Macular Edema
por: Kim, Jae Hui, et al.
Publicado: (2013) -
Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019) -
Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema: A prospective, randomized comparative study
por: Kucukevcilioglu, Murat, et al.
Publicado: (2015)